
PARP inhibitors alone and in combination with other biological agents in homologous recombination deficient epithelial ovarian cancer: From the basic research to the clinic
Keywords: تعمیر پایه پایه; Epithelial ovarian cancer; BRCA; Base excision repair; Homologous recombination deficiency; PARP inhibitors; Anti-angiogenic agents; Immune checkpoint inhibitors;